High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes
Clinical trial NCT07118670 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07118670
- Sponsor
- Edward Wood, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2028-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.